ESC 365 - The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity

Back

Open Access

The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity

Session: HOT LINE 2

Topic: Pharmacotherapy

Speaker: Professor S. Garrison (Edmonton, CA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Scott Garrison

University of Alberta, Edmonton (Canada)

2 presentations

2 followers

8 more presentations in this session

Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail

Speaker: Doctor R. Turgeon (Vancouver, CA)

Discussant review - BedMed, BedMed-Frail and Meta-analysis

Speaker: Professor I. Mackenzie (Dundee, GB)

Access

Slides

Video

Panel discussion - BedMed, BedMed-Frail and Meta-analysis

Access

Video

GMRx2 - Efficacy and safety of a novel triple single pill combination

Speaker: Professor A. Rodgers (Sydney, AU)

QUADRO - A single 4-drug combination in hypertension

Speaker: Professor S. Taddei (Pisa, IT)

Access the full session

HOT LINE 2

Speakers: Professor S. Garrison, Doctor R. Turgeon, Professor I. Mackenzie, Professor A. Rodgers, Professor S. Taddei

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources